Full Text View
Tabular View
No Study Results Posted
Related Studies
Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome
This study has been completed.
Study NCT00563771   Information provided by Sanofi-Aventis
First Received: November 21, 2007   Last Updated: January 24, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperuricemia
Additional conditions recognized in this trial
Syndrome
Tumor Lysis Syndrome
More general conditions related to this trial
Disease
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Pathologic Processes
Interventions listed in this trial
Rasburicase
More general drug interventions related to this trial
Antirheumatic Agents
Gout Suppressants
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services